Practical Use of Advagraf de Novo After Kidney Transplantation According to Recipient Genetic Polymorphism

NCT02311010 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Kidney Diseases

Interventions

DRUG: Advagraf

Sponsor

Université Catholique de Louvain